phage
display
technolog
regard
import
tool
use
discoveri
novel
ligand
variou
target
sinc
wide
employ
vitro
develop
monoclon
antibodi
trade
place
convent
hybridoma
technolog
still
mainli
anim
host
detail
review
antibodi
phage
display
provid
ponsel
et
tohidkia
et
zhao
et
identifi
target
specif
antibodi
vitro
select
process
underlin
affin
enrich
concept
known
biopan
commonli
affin
enrich
process
involv
sever
step
immobil
target
antigen
bind
phage
target
antigen
elimin
unbound
phage
elut
target
antigen
use
biopan
includ
recombin
protein
peptid
tissu
whole
main
assur
protein
mainli
prepar
good
puriti
yield
evid
report
antibodi
develop
dengu
herp
simplex
zika
ebola
plasmodium
mycobacterium
nematod
respons
nevertheless
sever
complic
anticip
antigen
express
hinder
avail
target
antigen
biopan
initi
solubl
antigen
govern
secret
antigen
cytoplasm
solubl
form
periplasm
solubl
form
inclus
bodi
insolubl
form
due
protein
aggreg
solubl
protein
desir
protein
purif
whilst
insolubl
protein
must
solubil
purifi
refold
overcom
issu
one
go
vigor
optim
process
includ
cultiv
temperatur
condit
express
use
differ
e
coli
express
host
coexpress
molecular
chaperon
fold
modul
fusion
partner
protein
detail
explan
recombin
protein
express
review
gupta
rosano
top
anoth
obstacl
quest
recombin
protein
product
purif
process
protein
purif
crude
extract
use
chromatographi
approach
cater
differ
properti
protein
common
approach
captur
desir
protein
independ
unwant
protein
use
affin
tag
like
glutathionestransferas
facilit
purif
even
purif
scheme
also
requir
tediou
optim
order
acquir
product
highest
puriti
recombin
antigen
pure
abund
use
biopan
henc
present
major
limit
attempt
develop
antibodi
challeng
target
antigen
light
establish
viabl
procedur
select
desir
antigen
crude
prepar
major
interest
herein
propos
proof
concept
pan
process
coin
yinyang
pan
use
antigen
prepar
devoid
purif
biopan
appli
process
isol
monoclon
scfv
middl
east
respiratori
syndrom
coronaviru
merscov
nucleoprotein
mersnp
yinyang
concept
take
name
taoist
concept
dualiti
strike
balanc
form
whole
crude
extract
consist
antigen
interest
nativ
form
alongsid
endogen
e
coli
protein
use
achiev
balanc
posit
neg
select
due
complex
microenviron
target
enrich
reduc
nonspecif
bind
interact
e
coli
protein
block
agent
paramount
allow
effect
antigenantibodi
interact
take
place
captur
elimin
step
introduc
prior
biopan
remov
influenc
binder
nontarget
protein
complet
workflow
outlin
follow
schemat
diagram
fig
propos
approach
abl
isol
monoclon
scfv
clone
mersnp
util
crude
prepar
antibodi
verifi
identifi
specif
mersnp
approach
highlight
possibl
carri
antibodi
phage
display
biopan
use
crude
antigen
identifi
antigen
specif
monoclon
antibodi
recombin
ubiquitin
rubi
protein
complementari
e
coli
lysat
prepar
biopan
simul
rmersnp
complementari
e
coli
lysat
produc
yinyang
biopan
rubi
rmersnp
well
complementari
e
coli
lysat
success
express
util
similar
host
strain
rubi
rmersnp
prepar
extract
analys
sdspage
crude
extract
show
presenc
nontarget
protein
similar
profil
antigen
prepar
fig
overexpress
rubi
rmersnp
also
visibl
respect
crude
prepar
thicker
band
purif
rubi
carri
presenc
antigen
confirm
via
western
blot
use
secondari
antibodi
fig
rubi
show
specif
band
expect
size
kda
good
yield
puriti
expect
band
size
rmersnp
protein
kda
initi
proof
concept
conduct
investig
bind
effici
antiubiquitin
scfv
phage
toward
rubi
complex
microenviron
biopan
total
four
differ
condit
complex
microenviron
test
stepwis
first
phage
assimil
differ
block
agent
pb
ptm
buffer
e
coli
lysat
combin
ptm
buffer
e
coli
lysat
phage
titr
determin
bind
rubi
phage
rubi
unbound
phage
collect
block
phage
bound
phage
elut
phage
fig
base
phage
titr
phage
show
good
bind
capac
toward
rubi
presenc
ptm
e
coli
lysat
amount
phage
also
rescu
despit
incub
differ
set
block
agent
nevertheless
highlight
combin
ptm
buffer
lysat
manag
block
larg
amount
phage
separ
sampl
set
extent
block
determin
calcul
ratio
differ
block
mixtur
ptm
buffer
lysat
set
block
agent
approxim
differ
block
combin
ptm
buffer
lysat
ptm
buffer
lysat
differ
record
ptm
buffer
lysat
combin
pb
cut
similar
ratio
differ
determin
block
sampl
set
cut
amount
block
ptm
buffer
lysat
combin
higher
respect
pb
lysat
ptm
show
combin
ptm
buffer
lysat
abl
captur
unbound
phage
block
agent
next
singl
round
biopan
simul
conduct
similar
fashion
investig
bind
capac
phage
toward
rubi
phage
mix
ratio
use
biopan
simul
phage
titr
across
sampl
determin
cfuml
cfuml
cfuml
cfuml
block
elut
block
elut
respect
supplementari
fig
bind
phage
toward
rubi
rel
good
despit
higher
amount
present
sampl
ratio
differ
unbound
elut
fraction
phage
across
sampl
fig
fold
chang
unbound
elut
across
sampl
larg
highest
ratio
differ
present
block
ptm
buffer
follow
combin
ptm
buffer
lysat
lysat
impli
block
agent
abl
captur
background
phage
reduc
nonspecif
bind
toward
antigen
lastli
crude
rubi
use
target
antigen
similar
biopan
simul
mention
collect
phage
titr
unbound
phage
cfuml
unbound
cfuml
slightli
higher
unbound
phage
unbound
compar
previou
simul
use
purifi
rubi
fraction
shown
supplementari
fig
hand
differ
elut
phage
elut
lower
compar
previou
simul
differ
elut
phage
elut
previou
simul
wherea
differ
drop
except
sampl
due
abrupt
drop
elut
bind
capac
phage
toward
rubi
crude
fraction
consist
previou
simul
similar
amount
elut
phage
determin
rang
cfuml
highest
ratio
differ
unbound
elut
phage
record
sampl
ptm
buffer
differ
follow
differ
record
sampl
ptm
buffer
lysat
ratio
differ
unbound
bound
highest
fold
chang
record
sampl
lysat
lowest
fold
chang
determin
sampl
ptm
buffer
lysat
differ
fig
differ
trend
exhibit
fold
chang
unbound
bound
phage
block
effect
ptm
buffer
lysat
abl
identifi
phage
elisa
conduct
measur
perform
effect
differ
block
agent
bind
phage
crude
rubi
four
sampl
combin
ptm
buffer
lysat
show
highest
signal
detect
anticmychrp
shown
fig
combin
block
agent
abl
control
interfer
background
phage
without
compromis
bind
capac
phage
therefor
combin
block
agent
use
next
stage
biopan
optim
optim
biopan
condit
crude
antigen
yinyang
captur
elimin
approach
design
reduc
nonspecif
bind
background
phage
approach
util
e
coli
lysat
ptm
block
microwel
follow
incub
phage
ptm
buffer
prepar
microwel
procedur
impos
captur
elimin
effect
phage
mixtur
enabl
nonspecif
phage
preoccupi
interf
bind
activ
initi
phage
subject
bind
purifi
rubi
unbound
phage
collect
block
phage
bound
phage
elut
phage
fig
overal
phage
titr
unbound
higher
compar
previou
optim
without
lysat
preblock
phage
preincub
approxim
also
differ
unbound
bound
larger
compar
last
optim
therefor
lysat
preblock
phage
preincub
found
reduc
nonspecif
bind
background
phage
effect
next
mixtur
ratio
subject
incub
ptm
buffer
lysateptmpreblock
microwel
yin
step
prior
bind
purifi
rubi
yang
step
higher
number
unbound
phage
cfuml
rescu
determin
supplementari
fig
increas
comparison
biopan
process
devoid
preblock
preincub
indic
yinyang
process
effici
remov
nonspecif
phage
particl
howev
higher
number
elut
phage
particl
also
obtain
indic
background
phage
recov
simul
nevertheless
bound
phage
slightli
higher
bound
ratio
differ
unbound
bound
phage
determin
fig
highest
differ
record
sampl
pb
wherea
lowest
differ
sampl
ptm
buffer
lysat
highest
fold
chang
unbound
bound
determin
sampl
ptm
buffer
follow
sampl
lysat
sampl
ptm
buffer
lysat
show
ptm
buffer
lysat
suitabl
preblock
phage
preincub
lastli
biopan
conduct
use
crude
rubi
target
antigen
base
phage
titr
supplementari
fig
amount
unbound
cfuml
similar
biopan
simul
use
purifi
rubi
indic
effici
e
coli
lysat
ptm
buffer
block
remov
nonspecif
interact
crude
fraction
bound
phage
number
bound
cfuml
howev
almost
bound
phage
cfuml
differ
pattern
expect
differ
bound
phage
previou
simul
pure
rubi
also
minim
notabl
amount
bound
sampl
ptm
buffer
lysat
higher
phage
show
domin
popul
empti
phage
elut
phage
rather
antibodi
present
phage
highest
fold
chang
unbound
bound
phage
record
sampl
ptm
follow
sampl
pb
sampl
ptm
lysat
fig
hand
highest
ratio
differ
unbound
bound
determin
sampl
pb
follow
ptm
buffer
lysat
combin
impli
yin
step
suffici
deplet
nonspecif
bind
moreov
bind
capac
phage
toward
crude
rubi
affect
yin
effect
contrast
help
control
interfer
background
phage
elut
phage
amplifi
packag
subsequ
phage
elisa
assess
yinyang
effect
utilis
differ
block
agent
four
sampl
combin
ptm
buffer
lysat
show
highest
signal
detect
anticmyc
hrp
shown
fig
despit
drop
bind
toward
crude
rubi
evid
lower
readout
could
conclud
yin
effect
essenti
use
ptm
buffer
lysat
combin
suitabl
reduc
nonspecif
interact
design
yin
effect
scfv
librari
construct
use
healthi
human
sampl
focus
igm
vh
vk
repertoir
divers
construct
antibodi
phagemid
librari
estim
coloni
pcr
perform
resolv
agaros
electrophoresi
shown
supplementari
fig
total
coloni
randomli
select
coloni
present
singl
band
expect
amplicon
size
approxim
bp
indic
fulllength
scfv
construct
incorpor
phagemid
vector
reason
success
rate
inhous
human
kappa
light
chain
scfv
librari
subject
yinyang
biopan
crude
rmersnp
higher
percentag
block
agent
increas
wash
stringenc
introduc
biopan
round
base
condit
earlier
optim
step
two
round
affin
select
enrich
specif
antirmersnp
antibodi
supplementari
fig
show
polyclon
elisa
result
crude
rmersnp
biopan
absorb
nm
slightli
low
first
second
round
biopan
respect
could
attribut
low
amount
rmersnp
present
total
crude
lysat
phage
titr
determin
indic
approxim
fold
enrich
observ
phage
enrich
tabul
supplementari
tabl
complement
polyclon
elisa
result
total
individu
clone
select
second
polyclon
pool
monoclon
elisa
assay
crude
rmersnp
posit
clone
identifi
cutoff
valu
normal
background
valu
readout
posit
control
monoclon
elisa
respect
label
p
neg
control
label
n
fig
overal
monoclon
elisa
assay
result
posit
binder
gener
human
librari
abl
provid
satisfactori
enrich
antirmersnp
preliminari
screen
coloni
pcr
subject
posit
clone
identifi
clone
fulllength
insert
identif
sequenc
sequenc
result
select
binder
analys
imgtvquest
determin
ident
scfv
monoclon
antibodi
clone
full
length
antibodi
clone
obtain
show
uniqu
combin
heavi
chain
kappa
light
chain
famili
addit
clone
found
delet
gene
segment
complementaritydetermin
region
cdr
categor
partial
clone
clone
present
umber
ochr
stop
codon
truncat
clone
also
obtain
antirmersnp
pool
compil
gene
segment
usag
full
clone
present
tabl
clone
success
express
inclus
bodi
subject
solubil
use
urea
buffer
ph
western
blot
use
streptavidinhrp
perform
detect
biotinyl
antibodi
fragment
shown
fig
purifi
recombin
antibodi
fragment
show
distinct
band
expect
size
kda
despit
expect
size
kda
ran
slightli
higher
kda
prepar
purifi
rmersnp
rgfp
elisa
detail
supplementari
method
express
profil
antigen
includ
supplementari
result
bind
profil
recombin
antibodi
fragment
determin
rang
rmersnp
sampl
set
incub
purifi
antibodi
order
assess
crossreact
antibodi
toward
protein
rgfp
use
total
purifi
rgfp
coat
allow
bind
antibodi
clone
respect
figur
show
bind
profil
respect
antibodi
fragment
toward
rmersnp
nm
normal
background
valu
control
fig
overal
bind
perform
best
dilut
seri
rmersnp
concentr
highest
absorb
valu
interact
toward
rmersnp
peak
concentr
bind
peak
concentr
rmersnp
readout
bind
toward
rmersnp
reach
appar
satur
concentr
antigen
reach
appar
satur
point
begin
rmersnp
background
valu
slightli
higher
respect
therefor
give
low
readout
normal
crossreact
profil
antibodi
fragment
toward
rgfp
absorb
normal
background
valu
shown
fig
data
also
take
consider
cross
reaction
streptavidinhrp
overal
antibodi
fragment
littl
bind
toward
control
antigen
readout
lower
therefor
antibodi
fragment
could
identifi
specif
toward
rmersnp
date
antibodi
phage
display
still
persist
method
commonli
use
gener
recombin
antibodi
variou
target
biomed
applic
robust
bacteriophag
display
antibodi
aid
expand
portfolio
target
antigen
includ
toxin
transmembran
protein
peptid
hapten
even
unfortun
problem
express
purif
e
coli
produc
recombin
protein
atyp
recombin
antigen
solubl
puriti
stabil
issu
difficult
exist
multipl
due
reason
need
develop
altern
procedur
select
toward
relev
antigen
present
complex
mixtur
especi
situat
rapid
antibodi
develop
requir
purifi
target
unavail
therefor
demonstr
captur
elimin
step
prior
affin
select
order
provid
subtract
effect
phage
popul
block
undesir
binder
via
bind
compon
block
mixtur
free
posit
binder
favour
bind
toward
relev
antigen
yinyang
pan
method
somewhat
akin
negativeposit
select
pan
strategi
wherebi
neg
select
aim
remov
unwant
binder
allow
posit
select
target
main
differ
studi
previou
method
approach
target
neg
select
target
neg
select
unspecif
antibodi
phage
binder
bind
protein
target
antigen
light
block
mixtur
mainli
use
deplet
neg
binder
previou
approach
polyclon
mab
use
target
unrel
epitop
present
phage
order
select
remov
allow
remain
phage
clone
select
antibodi
affin
toward
specif
moreov
yinyang
method
offer
two
round
neg
select
singl
round
biopan
one
posit
select
one
simultan
carri
posit
select
creat
competit
situat
small
number
unbound
neg
phage
compet
larg
number
unbound
posit
phage
target
antigen
presenc
targetunrel
protein
demonstr
inexpens
immobilis
strategi
targetunrel
protein
onto
solid
phase
neg
select
wherebi
unrel
protein
preoccupi
nonspecif
binder
either
bound
surfac
phage
mixtur
limit
method
inabl
remov
nonspecif
binder
prior
bind
howev
impos
stringent
wash
process
phage
elut
compens
therefor
phage
bind
unspecif
protein
wash
away
stringent
condit
subsequ
rescu
bound
phage
immobilis
plate
addit
method
also
adapt
membranebound
protein
use
western
blot
system
report
ding
et
liu
et
comparison
publish
enrich
strategi
yinyang
method
provid
tabl
preliminari
optim
perform
stepwis
manner
investig
strength
block
agent
toward
phage
bind
capabl
antibodi
phage
phage
without
antibodi
use
use
model
phage
optim
repres
specif
rubi
posit
binder
repres
popul
nonspecif
binder
mixtur
ptm
e
coli
lysat
exert
highest
block
effect
nonetheless
bulk
popul
cfuml
expect
satur
sampl
thu
allow
adsorb
bind
nonspecif
rubi
recov
later
bind
low
affin
toward
antigen
report
lamboy
et
modif
perform
reduc
unspecif
bind
simul
similar
condit
affin
select
mix
repres
cocktail
librari
phage
pan
rubi
purifi
crude
competit
expect
occur
posit
binder
nonspecif
binder
target
antigen
thu
competit
select
could
impos
satur
nonspecif
binder
competit
protein
lysat
ptm
therebi
promot
bind
toward
purifi
despit
presenc
unknown
e
coli
protein
crude
fraction
rubi
actual
concentr
rubi
expect
lower
purifi
rubi
bind
capabl
still
unaffect
shown
phage
elisa
assay
upon
affin
select
crude
rubi
block
effect
ptm
e
coli
lysat
highest
among
sampl
abl
block
compet
bia
titr
packag
phage
elisa
assay
normal
assay
yinyang
captur
elimin
step
preincub
phage
perform
well
coat
e
coli
lysat
subsequ
ptm
proper
block
surfac
block
agent
skim
milk
help
inhibit
unspecif
phage
preincub
enhanc
reduct
unspecif
binder
even
treat
idea
use
e
coli
lysat
protein
one
competit
protein
biopan
origin
whole
cell
biopan
approach
target
antigen
unrelev
protein
present
cell
lysat
theoret
could
expect
nonbind
deplet
yinyang
step
subsequ
allow
free
posit
binder
initi
bind
target
affin
select
yinyang
step
complement
block
effect
lysat
ptm
therebi
allow
nonbind
trap
evid
higher
number
unbound
record
howev
throughout
biopan
simul
rubi
purifi
crude
form
increas
number
nonbind
rescu
close
amount
posit
binder
rescu
could
attribut
insuffici
wash
result
rescu
nonbind
togeth
posit
binder
despit
rescu
phage
crude
rubi
amplifi
subject
phage
elisa
assay
determin
best
perform
sampl
best
perform
sampl
lysat
ptm
combin
gave
highest
readout
background
subtract
henc
demonstr
yinyang
step
crucial
biopan
crude
antigen
combin
ptm
lysat
help
control
reduc
disturb
nonbind
antigen
bind
nevertheless
due
rise
background
phage
elut
wash
stringenc
revis
accordingli
rational
coat
phage
preincub
well
lysat
ptm
inhibit
plastic
binder
interf
optim
neg
select
work
human
antibodi
phage
librari
gener
pan
merscov
nucleoprotein
librari
construct
healthi
donor
compris
three
ethnic
group
aim
expand
divers
antibodi
repertoir
highli
divers
antibodi
singl
pot
antibodi
librari
repertoir
univers
characterist
make
suitabl
employ
antibodi
select
wide
rang
target
gener
librari
highest
possibl
divers
size
qualiti
combinatori
mix
heavi
light
chain
perform
creat
possibl
gene
combin
vgene
repertoir
amplifi
use
gene
specif
primer
set
high
coverag
antibodi
addit
genet
divers
donor
sampl
three
ethnic
group
may
offer
addit
sequenc
divers
clone
effici
improv
perform
intermediari
clone
ensur
highest
incorpor
full
antibodi
gene
sequenc
destin
phagemid
vector
librari
gener
modest
divers
suffici
antibodi
select
despit
librari
report
yield
low
affin
binder
still
import
sourc
antibodi
correl
librari
divers
antibodi
affin
propos
directli
even
low
affin
binder
undergo
vitro
affin
matur
improv
bind
affin
kappa
light
chain
isotyp
sole
use
heavi
chain
igm
isotyp
repertoir
librari
kappa
antibodi
report
human
peripher
blood
lambda
antibodi
rearrang
kappa
isotyp
occur
earlier
kappa
allel
fail
rearrang
product
follow
lambda
howev
ratio
chang
upon
encount
antigen
suggest
light
chain
rearrang
occasion
take
place
b
cell
onset
somat
line
structur
physiochem
studi
kappa
lambda
antibodi
exhibit
differenti
characterist
adapt
immun
howev
context
sought
gener
librari
kappa
antibodi
studi
differenti
properti
lambda
kappa
antibodi
carri
later
studi
librari
subject
revis
affin
select
isol
antibodi
rmersnp
crude
prepar
yinyang
biopan
abl
enrich
antibodi
crude
rmersnp
round
select
low
enrich
ratio
expect
due
loss
binder
interf
protein
crude
fraction
method
abl
impos
competit
subtract
effect
onto
nonspecif
binder
order
increas
possibl
posit
binder
bind
target
extrem
low
amount
reproduc
method
fairli
good
good
enrich
achiev
sever
attempt
use
inhous
antibodi
librari
differ
target
data
shown
mab
select
done
full
antibodi
clone
obtain
work
base
sequenc
analysi
vgene
combin
clone
antibodi
fragment
express
purifi
bind
specif
determin
toward
rmersnp
bind
specif
rmersnp
minim
background
signal
present
degre
background
signal
indic
clone
low
perform
clone
notic
slight
differ
antibodi
band
migrat
may
like
due
introduct
chemic
case
biotinyl
contribut
retard
gel
migrat
addit
previou
report
examin
effici
biotinyl
compar
gel
migrat
biotinyl
product
nonbiotinyl
product
presenc
streptavidin
reveal
slower
migrat
biotinyl
despit
three
antibodi
fragment
underw
biotinyl
gel
shift
effect
drastic
approxim
kda
differ
comparison
previous
report
neutral
mab
merscov
specif
receptorbind
domain
rbd
spike
glycoprotein
rbd
merscov
bind
human
dipeptidyl
peptidas
cellular
receptor
gain
entri
target
cell
viral
infect
report
mab
focus
neutral
rbd
block
interact
rbd
extrem
potenc
exhibit
mab
target
rbd
despit
anoth
potenti
target
neutral
also
particularli
import
molecul
immun
regul
cell
activ
chemokin
function
therefor
clinic
use
unadvis
advers
side
effect
may
recent
report
combin
mab
specif
rbd
nonrbd
domain
glycoprotein
initi
neutral
enhanc
differ
antigen
site
protein
nevertheless
immun
escap
alway
endeavour
coronavirus
express
mutant
protein
nucleocapsid
protein
less
mutat
abund
np
merscov
make
anoth
potenti
candid
target
protein
np
respons
viral
genom
rna
packag
transcript
previou
report
three
mab
merscov
rbd
except
potenc
found
origin
heavi
chain
interestingli
studi
found
clone
target
np
also
belong
heavi
chain
famili
note
gene
also
found
util
antivir
antibodi
target
influenza
viru
hepat
c
yinyang
method
togeth
scfv
librari
abl
select
antibodi
complex
antigen
provid
competit
subtract
effect
favour
bind
posit
binder
permit
antigen
differ
state
complex
mixtur
low
puriti
protein
cocktail
gain
excess
affin
bind
without
limit
protein
puriti
yield
like
optim
approach
requir
differ
antigen
produc
differ
host
cell
due
differ
cell
content
gener
kappa
light
chain
scfv
librari
abl
gener
mab
merscov
np
use
propos
approach
crude
rmersnp
therefor
kappa
exclus
librari
potenti
use
isol
antibodi
interest
antigen
futur
conclus
yinyang
pan
togeth
kappa
scfv
librari
use
altern
select
process
mab
gener
challeng
target
antigen
escherichia
coli
dcm
ompt
hsdsb
gal
e
coli
dcm
ompt
hsdsb
rb
mb
gal
agil
technolog
santa
clara
ca
usa
e
coli
lac
pro
araleu
lacz
phoa
pvuii
phor
ahpc
gale
u
galk
specr
laciq
strr
malf
new
england
biolab
neb
usa
e
coli
supe
lacproab
mcrbhsdsm
proab
laciq
agil
technolog
santa
clara
ca
usa
e
coli
lac
proab
laciq
tetr
agil
technolog
santa
clara
ca
usa
e
coli
top
f
mcra
mrrhsdrmsmcrbc
araleu
galu
galk
rpsl
strr
nupg
invitrogen
usa
helper
plasmid
encod
biotin
ligas
rare
trna
well
plasmid
obtain
dr
zoltan
konthur
max
planck
institut
molecular
genet
berlin
germani
vector
acquir
invitrogen
plabel
phagemid
use
incorpor
scfv
fragment
phagemid
librari
gener
rgfp
scfv
adapt
ismail
n
f
et
propag
amplif
well
phage
packag
perform
accord
hust
hust
lim
et
prepar
rubi
complementari
e
coli
lysat
recombin
plasmid
bear
ubi
gene
empti
plasmid
helper
plasmid
introduc
e
coli
strain
transform
cell
grown
media
supplement
vv
glucos
ampicillin
chloramphenicol
mm
isopropyl
iptg
h
bacteri
cell
pellet
collect
subject
cytoplasm
extract
mgml
lysozym
follow
min
sonic
ice
imac
purif
perform
rubi
use
ml
ninta
agaros
fast
flow
column
ge
healthcar
recombin
plasmid
bear
mersnp
gene
express
similar
fashion
use
e
coli
strain
follow
cytoplasm
extract
crude
protein
lysat
subject
sdspage
analysi
optim
done
stepwis
investig
bind
capac
antibodi
toward
antigen
variou
block
agent
targetunrel
protein
initi
onestep
affin
select
perform
separ
purifi
rubi
presenc
variou
block
agent
eight
microwel
coat
purifi
rubi
pb
buffer
overnight
well
wash
three
time
vv
pbst
block
ptm
block
buffer
wv
skim
milk
pbst
h
rpm
agit
room
temperatur
rt
simultan
phage
cfuml
cfuml
block
separ
set
block
agent
total
volum
pb
buffer
ii
ptm
iii
e
coli
lysat
iv
ptm
e
coli
lysat
incub
took
place
h
rt
gentl
agit
rpm
antigenco
well
wash
three
time
pbst
block
phage
transfer
well
accordingli
bind
took
place
rt
h
rpm
phage
mixtur
collect
end
incub
unbound
phage
well
wash
three
time
pbst
bound
phage
elut
enzymat
digest
trypsin
pb
buffer
min
static
serial
dilut
perform
unbound
elut
phage
serial
dilut
phage
allow
infect
exponenti
grow
cultur
min
static
phage
titr
determin
spot
agar
agar
plate
titr
data
collect
block
phage
elut
phage
next
biopan
simul
carri
use
mixtur
cfuml
cfuml
purifi
crude
rubi
similar
condit
prepar
antigenco
well
ptmpreblock
well
similar
mixtur
phage
block
set
block
agent
total
volum
pb
buffer
ii
ptm
iii
e
coli
lysat
iv
ptm
e
coli
lysat
block
phage
took
place
h
rpm
agit
rt
subsequ
transfer
antigenco
well
bind
phage
titr
data
unbound
phage
elut
phage
determin
biopan
simul
crude
rubi
crude
rubi
coat
onto
microwel
pb
buffer
total
protein
concentr
crude
rubi
measur
nanodrop
thermo
fischer
scientif
usa
procedur
similar
second
stage
optim
perform
preincub
phage
prior
affin
select
target
antigen
purifi
rubi
pb
buffer
coat
onto
microwel
overnight
sampl
set
concurr
number
well
block
e
coli
lysat
overnight
antigenco
well
lysat
preblock
well
subject
three
time
pbst
wash
well
block
ptm
block
buffer
h
rt
rpm
lysateptmco
well
wash
three
time
pbst
use
phage
block
incub
variou
block
agent
lysateptmco
well
separ
phage
transfer
antigenco
well
bind
occur
phage
titr
block
phage
elut
phage
determin
biopan
simul
mixtur
preincub
prior
affin
select
purifi
crude
rubi
rescu
phage
biopan
simul
crude
rubi
optim
packag
amplifi
phage
subject
phage
elisa
assay
assess
bind
perform
presenc
variou
block
agent
detail
workflow
includ
supplementari
method
total
cdna
healthi
human
donor
three
local
ethnic
group
malay
chines
indian
use
start
materi
librari
gener
collect
human
blood
sampl
total
lymphocyt
isol
prepar
cdna
librari
clone
perform
accord
lim
et
slight
modif
sampl
collect
perform
accord
human
ethic
approv
human
ethic
committe
univers
sain
malaysia
donor
inform
project
gave
inform
consent
donor
healthi
individu
known
infect
physic
healthi
month
collect
detail
protocol
librari
gener
describ
supplementari
method
affin
select
process
separ
step
first
step
carri
captur
nonspecif
phage
present
phage
librari
prepar
second
step
biopan
filter
phage
previou
step
target
antigen
total
mg
crude
rmersnp
pb
buffer
coat
surfac
micropl
well
h
simultan
immunotub
high
bind
surfac
block
equal
volum
e
coli
lysat
gener
e
coli
strain
empti
ptm
rotat
h
interv
wash
perform
time
pbst
antigenco
well
block
ptm
buffer
h
rpm
rt
ying
affin
select
done
immunotub
preincub
librari
phage
librari
phage
cfuml
ptm
e
coli
lysat
h
rotat
rt
content
immunotub
transfer
well
incub
h
rpm
yang
affin
select
end
bind
well
wash
pbst
pb
buffer
vv
tween
time
time
subsequ
round
biopan
bound
phage
elut
trypsin
min
e
coli
cultur
infect
trypsinelut
phage
particl
first
round
biopan
phageinfect
cell
propag
phage
particl
packag
use
second
round
biopan
trypsinelut
phage
two
biopan
round
amplifi
packag
two
well
coat
mg
crude
rmersnp
concurr
anoth
two
well
block
ptm
background
control
enrich
phage
block
equal
volum
ptm
lysat
lysateptmblock
immunotub
describ
phage
mixtur
incub
antigenco
background
well
h
similar
biopan
condit
peroxidas
hrp
use
detect
bound
phage
h
rt
rpm
acid
diammonium
salt
abt
use
develop
colorimetr
signal
enrich
pattern
determin
absorb
nm
monoclon
phage
elisa
carri
use
protocol
accord
lim
et
slight
modif
briefli
phage
particl
highest
enrich
subject
infect
singl
coloni
pick
cultur
perform
monoclon
assay
mg
crude
rmersnp
ptm
use
sole
block
agent
three
time
wash
pbst
use
interv
wash
monoclon
phage
particl
transfer
antigenco
elisa
micropl
incub
h
rpm
hrp
introduc
detect
phage
bind
follow
abt
develop
solut
absorb
measur
within
min
detail
protocol
outlin
supplementari
method
posit
clone
monoclon
elisa
cultur
rpm
h
cell
pellet
collect
plasmid
extract
perform
use
qiaprep
spin
miniprep
kit
qiagen
germani
purifi
plasmid
sent
sequenc
first
base
laboratori
sdn
bhd
malaysia
sequenc
result
analys
imgtvquest
bioinformat
tool
avail
intern
immunogenet
inform
dna
amplifi
respect
plabel
vector
clone
e
coli
express
vector
restrict
site
ncoi
noti
neb
usa
result
vector
name
express
perform
vivo
biotinyl
express
condit
biotinyl
optim
rpm
h
iptg
induct
final
concentr
mm
dbiotin
inclus
bodi
biotinyl
solubil
use
urea
buffer
ph
urea
tri
urea
crude
fraction
subject
protein
purif
use
ninta
agaros
graviti
column
qiagen
germani
denatur
condit
initi
column
equilibr
urea
buffer
ph
follow
sampl
load
column
subject
wash
ml
urea
buffer
ph
step
elut
perform
urea
buffer
ph
lastli
ml
elut
fraction
collect
stepwis
protein
fraction
analys
sdspage
last
fraction
combin
subject
buffer
exchang
use
ultra
ml
centrifug
filter
merck
darmstadt
germani
antibodi
fragment
dissolv
pb
buffer
ph
western
blot
perform
use
streptavidinhrp
thermo
scientif
usa
detect
confirm
respect
antibodi
fragment
purifi
rmersnp
fuse
fraction
purifi
rgfp
fuse
fraction
purifi
antibodi
fragment
quantifi
detail
supplementari
method
serial
dilut
purifi
rmersnp
coat
onto
microwel
pb
buffer
total
volum
overnight
interv
wash
perform
time
pbst
antigenco
well
block
ptm
block
buffer
h
rt
rpm
respect
antibodi
fragment
resuspend
pb
buffer
aliquot
repres
postblock
well
wash
well
ad
antibodi
fragment
addit
empti
well
also
ad
antibodi
fragment
neg
control
well
check
crossreact
antibodi
toward
protein
well
coat
rgfp
subsequ
allow
incub
antibodi
fragment
antigenantibodi
bind
took
place
rpm
h
streptavidinhrp
dilut
ptm
block
buffer
ad
well
incub
h
rt
rpm
detect
antigenantibodi
bind
lastli
abt
develop
solut
ad
wash
absorb
measur
within
h
